Dow Up 0.08% Nasdaq Down 0.30%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
7.08 Down 0.23(3.08%) Sep 19, 4:00PM EDT
|After Hours : 7.24 Up 0.16 (2.26%) Sep 19, 5:23PM EDT
Prev Close:7.31
Open:7.37
Bid:7.11 x 1100
Ask:7.57 x 3000
1y Target Est:12.89
Beta:1.97
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:7.06 - 7.41
52wk Range:6.04 - 13.64
Volume:598,062
Avg Vol (3m):1,128,220
Market Cap:307.11M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 3.08%307.11M
BAXDown 0.77%39.29B
CFNUp 0.06%9.48B
HSPUp 0.64%9.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.09
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback